Attached files
file | filename |
---|---|
10-K - FORM 10-K - ALBIREO PHARMA, INC. | y80991e10vk.htm |
EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | y80991exv21w1.htm |
EX-10.20 - EX-10.20 - ALBIREO PHARMA, INC. | y80991exv10w20.htm |
EX-32.01 - EX-32.01 - ALBIREO PHARMA, INC. | y80991exv32w01.htm |
EX-10.22 - EX-10.22 - ALBIREO PHARMA, INC. | y80991exv10w22.htm |
EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | y80991exv31w02.htm |
EX-10.19 - EX-10.19 - ALBIREO PHARMA, INC. | y80991exv10w19.htm |
EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | y80991exv31w01.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Board of Directors and Stockholders
Biodel Inc.
Danbury, Connecticut
Biodel Inc.
Danbury, Connecticut
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3
(File No. 333-153167) and the Registration Statement on Form S-8 (File No. 333-144407) of our
reports dated December 14, 2009, relating to the financial statements and effectiveness of Biodel
Inc.s internal control over financial reporting which appear in the Companys Form 10-K for the
year ended September 30, 2009.
/s/ BDO Seidman, LLP
New York, New York
December 14, 2009
December 14, 2009